Paul Dick, D.V.M., M.Sc.

  • ~30 years animal health industry experience
  • President of Paul Dick & Associates – strategic advisor to established and emerging animal health companies
  • CEO of Chemaphor – publicly-traded natural products company
  • Canadian COO, R&D, Regulatory Affairs at Elanco – Eli Lilly’s animal health business

Michael Hemprich, D.V.M.

  • ~20 years animal health industry experience
  • Head of Business Development at IDT-Biologika GmbH – privately-held company focused on R&D, manufacturing and distribution of biologics
  • Business Development Director, Country Manager at Dechra Pharmaceuticals – publicly-traded international specialty veterinary pharmaceuticals business
  • VP Business Development and R&D at LAB International – publicly-traded drug development company/CRO

Michael Kaswan, M.B.A.

  • ~25 years venture capital/private equity and finance/operating experience
  • Founder/CEO of Persante Health Care – private equity backed healthcare services company
  • Partner at KBL Healthcare Ventures – healthcare-focused venture capital fund and private equity firm
  • Co-founder of Georgia Veterinary Specialists – founding partner in BluePearl Veterinary Partners

Seth Zalkin, J.D.

  • ~20 years private equity, investment banking and operating experience
  • Managing Partner of Astor Group and Astor Capital – investment advisory and merchant banking firm focused on consumer brands and innovative technology companies in the Americas
  • Chairman of Brooklyn Brands – led private equity deal for this artisanal baked products company
  • CEO of ClubPlanet and Way Communications – innovative start-ups with successful exits